C, K., ML, M., RK, S., CM, S., AJ, F., HF, R., . . . JL, K. (2025). Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosis. Antimicrobial agents and chemotherapy, 69(1), e0153924. https://doi.org/10.1128/aac.01539-24
Chicago Style (17th ed.) CitationC, Koenig, et al. "Cefiderocol Pharmacokinetics During Acute Pulmonary Exacerbations in Hospitalized Adult Persons with Cystic Fibrosis." Antimicrobial Agents and Chemotherapy 69, no. 1 (2025): e0153924. https://doi.org/10.1128/aac.01539-24.
MLA (9th ed.) CitationC, Koenig, et al. "Cefiderocol Pharmacokinetics During Acute Pulmonary Exacerbations in Hospitalized Adult Persons with Cystic Fibrosis." Antimicrobial Agents and Chemotherapy, vol. 69, no. 1, 2025, p. e0153924, https://doi.org/10.1128/aac.01539-24.